This alteration leads to the uncontrolled growth and spread of the tumor cells, which is a crucial reason why ALK-positive NSCLC is more aggressive and resistant to traditional chemotherapy treatment than NSCLC without this alteration (4). The gene discussed is ALK; the disease is neoplasm.